Barriers impeding serologic screening for celiac disease in clinically high-prevalence populations.

ABSTRACT:

Background

Celiac disease is present in ~1% of the general population in the United States and Europe. Despite the availability of inexpensive serologic screening tests, ~85% of individuals with celiac disease remain undiagnosed and there is an average delay in diagnosis of symptomatic individuals with celiac disease that ranges from ~5.8-11 years. This delay is often attributed to the use of a case-based approach for detection rather than general population screening for celiac disease, and deficiencies at the level of health care professionals. This study aimed to assess if patient-centered barriers have a role in impeding serologic screening for celiac disease in individuals from populations that are clinically at an increased risk for celiac disease.

Methods

119 adults m

SUBMITTER: Barbero EM 

PROVIDER: S-EPMC4016507 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature